Search Results

Late Endograft Failure

Improvements in preclinical testing will help reduce the risk of failure.

By HUGH G. BEEBE, MD

Current Perspective on Self-Expanding Stents for Acute Ischemic Stroke

Experience with this technique and a preview of the first FDA-approved prospective trial, SARIS.

By Elad I. Levy, MD, FACS, FAHA; Sabareesh K. Natarajan, MD, MS; Adnan H. Siddiqui, MD, PhD; Kenneth V. Snyder, MD, PhD; Erik F. Hauck, MD, PhD; J Mocco, MD, MS; and L. Nelson Hopkins, MD, FACS

Advances in the Medical Management of Venous Thromboembolism

A review of the current data on VTE prevention and treatment using a variety of pharmacologic options.

By John N. Makaryus, MD, and Joe F. Lau, MD, PhD

Endovascular Intervention of Iliofemoral Venous Thrombosis

Is there a role for percutaneous pharmacomechanical thrombectomy?

By Peter H. Lin, MD; Eric Peden, MD; Wei Zhou, MD; and Alan B. Lumsden, MD

Is Pure Endovascular Treatment the New Frontier?

Chimney and sandwich techniques offer promising options for aneurysm exclusion.

By Armando C. Lobato, MD, PhD; Marcelo Cury, MD; Fabio Luiz Costa Pereira, MD; Vasco Gama Ribeiro, MD; and Luciana Camacho-Lobato, MD, PhD

Dialysis Access Interventions: What Was and What’s Flowing Next

A summary of this past year's most important papers, top headlines in dialysis access, and what to expect for the future of the field.

By James Chen, MD; Brian Holly, MD; and Mark Lessne, MD

Special Considerations for Embolization in Trauma Cases

Clinical indicators and arterial embolization techniques.

By Jason Salsamendi, MD; David Quintana, MD; Issam Kably, MD; and Govindarajan Narayanan, MD

Prediction Models for Pulmonary Embolism

Considering the available prediction models for estimating the pretest probability and posttest severity of patients with PE, how these models can be applied in clinical practice, and the potential for intervention prediction models.

By Drew A. Birrenkott, MD, DPhil, and Christopher Kabrhel, MD, MPH

Vascular Access Surveillance With Angioplasty: A Halfway Technology?

The role of access surveillance combined with angioplasty to achieve the goal of reducing vascular access thrombosis and prolonging access survival in hemodialysis patients.

By Jack Work, MD

Spinal Cord Ischemia Management: Current Indications and Timing for Drainage

Current indications for drainage, prophylactic versus selective drain protocols, and ideal timing if drainage is indicated.

By Alexander S. Fairman, MD, and Grace J. Wang, MD, MSCE

The Future of Artificial Intelligence in Interventional Oncology

Potential applications of AI within IO include patient diagnosis, response prediction, and intraprocedural guidance, dependent upon standardized and responsible implementation.

By Helen Zhang, BS; Shreyas Kulkarni, BS; Zhicheng Jiao, PhD; and Harrison X. Bai, MD, MS

Determining Cost-Effectiveness in CLI Therapy

Weighing clinical benefits along with cost when selecting therapies is more important than ever.

By Firas F. Mussa, MD, MS, with commentary by Mary L. Yost, MBA

Where Do We Stand on Truly Uncomplicated TBAD? It’s Complicated

The management of uTBAD remains controversial—mostly due to difficulty identifying patients with truly uTBAD.

By Sophia Khan, MD, and Rana O. Afifi, MD